Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In response to: “Reply to research letter”

Journal of the American Academy of Dermatology(2020)10.1016/j.jaad.2020.07.097Source: DataRank Database

In response to: “Reply to research letter” is a research paper published in Journal of the American Academy of Dermatology (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: bronzeTopics (34)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Daniel B. Shin ORCID,Kevin Winthrop ORCID,Joel M. Gelfand ORCID,Marilyn T. Wan ORCID

Live enrichment

PubMed:32735975 OpenAlex:https://openalex.org/W3045843064

National Institutes of Health

Grant: P30-AR-069589-03

National Institutes of Health

Grant: 5P30AR069589-03

Penn Resource-based Center to Support and Translate Skin DiseasesResearch

NIAMS NIH HHS

Grant: P30 AR069589

FWCI

0.00

Citation Percentile

0.1%

bronzeLicense: Elsevier TDM

journalhttp://www.jaad.org/article/S0190962220322982/pdf

publisherhttp://www.jaad.org/article/S0190962220322982/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0190962220322982?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0190962220322982?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaad.2020.07.097

Fields of Study

Pharmacovigilance and Adverse Drug ReactionsHealth Systems, Economic Evaluations, Quality of LifePharmaceutical industry and healthcare03 medical and health sciences0302 clinical medicineBiological ProductsCOVID-19Decision MakingHumansInterleukin-17PandemicsPsoriasisRespiratory Tract InfectionsSARS-CoV-2

MeSH Terms

COVID-19SARS-CoV-2Biological ProductsDecision MakingHumansPsoriasisRespiratory Tract InfectionsInterleukin-17Pandemics

Keywords

MedicineBiological ProductsSARS-CoV-2Decision MakingInterleukin-17COVID-19HumansPsoriasisPandemicsRespiratory Tract InfectionsJAAD Online

Sustainable Development Goals

SDG 0: Good health and well-being